Standardization of common bile duct size using ultrasound in pediatric patients

Erika B Lindholm1, Teerin Meckmongkol1, Ari J Feinberg2

  • 1Division of Pediatric General, Thoracic and Minimally Invasive Surgery, St. Christopher's Hospital for Children, Philadelphia, PA.

Insights

Establishing normal common bile duct (CBD) size in children using ultrasound is crucial for diagnosing obstruction. Pediatric CBD diameters are significantly smaller than adult norms, improving diagnostic accuracy for choledocholithiasis.

Area of Science:

  • Pediatric Gastroenterology
  • Diagnostic Imaging
  • Hepatobiliary Surgery

Background:

  • The incidence of choledocholithiasis (gallstones in the common bile duct) is rising.
  • Accurate diagnosis of common bile duct (CBD) obstruction relies on measuring CBD diameter.
  • Current diagnostic criteria often use adult norms, potentially leading to inaccuracies in pediatric cases.

Purpose of the Study:

  • To establish normative values for common bile duct (CBD) size in children across different age groups using ultrasound.
  • To validate these pediatric norms against cases of confirmed choledocholithiasis.
  • To improve the diagnostic accuracy for CBD obstruction in pediatric patients.

Main Methods:

  • Retrospective review of ultrasounds (US) in patients under 21 years old.
  • Stratification of patients into age groups (<1 year, 1-10 years, >10 years) for analysis.
  • Comparison of normal cohort CBD sizes with those of patients diagnosed with choledocholithiasis.

Main Results:

  • A cohort of 778 patients without pathology established normal CBD size ranges: <1 year (1.24±0.54 mm), 1-10 years (1.97±0.71 mm), and >10 years (2.98±1.17 mm).
  • Patients with choledocholithiasis (n=14) had a mean CBD size of 8.1 mm, with all falling outside the established pediatric normal range.
  • Only 50% of choledocholithiasis cases showed enlarged CBD size when compared to adult norms, highlighting the inadequacy of adult standards for children.

Conclusions:

  • Normal common bile duct (CBD) size in children is considerably smaller than in adults.
  • Implementing age-specific pediatric CBD size norms enhances the diagnostic accuracy for identifying CBD obstruction.
  • These findings will aid clinicians in determining the need for further evaluation in children with suspected CBD obstruction.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
Common Ion Effect03:24

Common Ion Effect

Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
46.2K
Bile01:19

Bile

Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
4.1K